Market Cap 18.33M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 336,200
Avg Vol 66,844
Day's Range N/A - N/A
Shares Out 1.88M
Stochastic %K 21%
Beta 1.39
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
JediGreen
JediGreen Dec. 23 at 10:10 PM
$BCTX This stock reminds me of the Rocky movies. We might see something none of us ever have seen. 
1 · Reply
JediGreen
JediGreen Dec. 23 at 10:01 PM
$BCTX To all the hundred dollar billers. Not a shook one.
0 · Reply
JediGreen
JediGreen Dec. 23 at 9:59 PM
$BCTX just remember 2-5 billion bri IMT opportunity. Bullish baby. Phase 3 coming
0 · Reply
Fvalstounge
Fvalstounge Dec. 23 at 8:09 PM
$BCTX Unfortunately, when you always hand out warrants like bowling coupons, you severely undermine your own value proposition, with predictable results. SMH.
0 · Reply
Susquehanna
Susquehanna Dec. 23 at 7:47 PM
$BCTX Fair warning to anyone trying to remain bullish... This was just the S-1 getting filed. Go back to July and they filed the S-1 for that offering on July 8 in the after hours. Look at what happened to the price the next trading day (July 9)... Down 27%. But that meant the worst was surely behind, right? Nah, they priced the offering at a huge discount intra-day on July 15, which sent the price plummeting an additional 62%. I still love the science here, but the market is quite possibly giving anyone still in a gift right now, only being down 21% today. The prospectus calls for a massive dilution more than doubling the outstanding share count. If it goes through as written, it's likely going to result in a repeat of what happened in July. Preserve your capital and come back after the dust settles, if you still like the science, like me.
2 · Reply
FredFlintstock
FredFlintstock Dec. 23 at 6:46 PM
$BCTX all these bullish pumpers dont even know about bria ots. They think imt is whats going to get the company bought out. 🤣🤣 Keep on throwing money at it, only another 3 or 4 offerings to go. 🤣🤣
0 · Reply
Fvalstounge
Fvalstounge Dec. 23 at 6:05 PM
$BCTX On the science side, there are some changes you likely aren't aware of. Going back to the 2022 SABCS poster, the company's literature has frequently referenced the cytokines and costimulatory molecules that would be expressed by the next-generation OTS cell lines. Among those was 4-1BBL (induces a proliferation of active T-cells). Engineering 4-1BBL expressions is fraught with specific challenges, including a very high vector load (takes up a lot of available space in the lentiviral vectors), inconsistent expressions and needs to be bound to the cell surface without cleaving. It definitely can complicate GMP manufacturing. As it turns out, those challenges have persisted and they will NOT be engineering that expression into future therapies. It's just not worth further effort. Not a bad thing, IMO. It opens up room for other expressions that are just as useful, but easier and more consistent (like CD40L being added to Bria-MEL and Bria-LUNG). Now you know.
0 · Reply
superguild
superguild Dec. 23 at 5:49 PM
$BCTX there goes my fantasy of the BCTXZ warrants being worth something someday
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 23 at 5:30 PM
$BCTX RSI: 24.08, MACD: -0.4215 Vol: 1.43, MA20: 10.17, MA50: 10.49 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Kirubin
Kirubin Dec. 23 at 4:44 PM
$BCTX where’s JJ at? apologize!
0 · Reply
Latest News on BCTX
BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 2 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025


BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 21, 2025, 12:00 PM EDT - 4 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation


BriaCell CEO Letter to Shareholders

May 20, 2025, 7:30 AM EDT - 7 months ago

BriaCell CEO Letter to Shareholders


BriaCell Announces Four Clinical Data Presentations at ASCO 2025

Apr 23, 2025, 7:30 AM EDT - 8 months ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025


BriaCell Therapeutics Announces Closing of Public Offering

Feb 5, 2025, 4:05 PM EST - 11 months ago

BriaCell Therapeutics Announces Closing of Public Offering


JediGreen
JediGreen Dec. 23 at 10:10 PM
$BCTX This stock reminds me of the Rocky movies. We might see something none of us ever have seen. 
1 · Reply
JediGreen
JediGreen Dec. 23 at 10:01 PM
$BCTX To all the hundred dollar billers. Not a shook one.
0 · Reply
JediGreen
JediGreen Dec. 23 at 9:59 PM
$BCTX just remember 2-5 billion bri IMT opportunity. Bullish baby. Phase 3 coming
0 · Reply
Fvalstounge
Fvalstounge Dec. 23 at 8:09 PM
$BCTX Unfortunately, when you always hand out warrants like bowling coupons, you severely undermine your own value proposition, with predictable results. SMH.
0 · Reply
Susquehanna
Susquehanna Dec. 23 at 7:47 PM
$BCTX Fair warning to anyone trying to remain bullish... This was just the S-1 getting filed. Go back to July and they filed the S-1 for that offering on July 8 in the after hours. Look at what happened to the price the next trading day (July 9)... Down 27%. But that meant the worst was surely behind, right? Nah, they priced the offering at a huge discount intra-day on July 15, which sent the price plummeting an additional 62%. I still love the science here, but the market is quite possibly giving anyone still in a gift right now, only being down 21% today. The prospectus calls for a massive dilution more than doubling the outstanding share count. If it goes through as written, it's likely going to result in a repeat of what happened in July. Preserve your capital and come back after the dust settles, if you still like the science, like me.
2 · Reply
FredFlintstock
FredFlintstock Dec. 23 at 6:46 PM
$BCTX all these bullish pumpers dont even know about bria ots. They think imt is whats going to get the company bought out. 🤣🤣 Keep on throwing money at it, only another 3 or 4 offerings to go. 🤣🤣
0 · Reply
Fvalstounge
Fvalstounge Dec. 23 at 6:05 PM
$BCTX On the science side, there are some changes you likely aren't aware of. Going back to the 2022 SABCS poster, the company's literature has frequently referenced the cytokines and costimulatory molecules that would be expressed by the next-generation OTS cell lines. Among those was 4-1BBL (induces a proliferation of active T-cells). Engineering 4-1BBL expressions is fraught with specific challenges, including a very high vector load (takes up a lot of available space in the lentiviral vectors), inconsistent expressions and needs to be bound to the cell surface without cleaving. It definitely can complicate GMP manufacturing. As it turns out, those challenges have persisted and they will NOT be engineering that expression into future therapies. It's just not worth further effort. Not a bad thing, IMO. It opens up room for other expressions that are just as useful, but easier and more consistent (like CD40L being added to Bria-MEL and Bria-LUNG). Now you know.
0 · Reply
superguild
superguild Dec. 23 at 5:49 PM
$BCTX there goes my fantasy of the BCTXZ warrants being worth something someday
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 23 at 5:30 PM
$BCTX RSI: 24.08, MACD: -0.4215 Vol: 1.43, MA20: 10.17, MA50: 10.49 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Kirubin
Kirubin Dec. 23 at 4:44 PM
$BCTX where’s JJ at? apologize!
0 · Reply
Makessense
Makessense Dec. 23 at 4:12 PM
$BCTX 🤡
0 · Reply
JediGreen
JediGreen Dec. 23 at 3:36 PM
$BCTX if this goes green today it’s going to make the bears spin their heads. 😆 
0 · Reply
UgoGreg
UgoGreg Dec. 23 at 3:31 PM
$BCTX https://youtu.be/6GeRpvlSBgw
0 · Reply
Fvalstounge
Fvalstounge Dec. 23 at 3:28 PM
$BCTX Easily the least surprising offering to date. Anyone paying attention knew they had to have more cash to reach the interim review. I doubt they raise the entire goal of $25M, but should be more than enough to get across the finish line.
1 · Reply
ViVega1
ViVega1 Dec. 23 at 3:23 PM
$BCTX bought, at these price cheap imo. GL
0 · Reply
powersofcompound
powersofcompound Dec. 23 at 3:05 PM
$BCTX nice vol so far, see if it can push through 8, has a massive phase3 topline readout next year. $NVO
4 · Reply
JediGreen
JediGreen Dec. 23 at 2:59 PM
$BCTX I would not doubt if we see a stampede come In soon.
0 · Reply
MarkeTimer
MarkeTimer Dec. 23 at 2:42 PM
$BCTX Shameless
0 · Reply
Theoption
Theoption Dec. 23 at 2:35 PM
$BCTX 😂😂😂😂 Some things never change.
0 · Reply
JanetBSmellin
JanetBSmellin Dec. 23 at 2:27 PM
$BCTX If I was still holding my shares from 2022, I’d be down 97% here….. 😵‍💫
0 · Reply
Stmkr
Stmkr Dec. 23 at 2:24 PM
$BCTX Is this finally the last offering before pivotal readout?
1 · Reply